Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Prostatic Neoplasms 1Peripheral Nervous System Diseases 1Nocturia 1Bronchiolitis Obliterans Syndrome 1Breast Neoplasms 1

Interventions

ibrutinib 2fludarabine 2Sirolimus 2Rituximab 2Mycophenolic Acid 2Cyclophosphamide 2oblimersen 1Whole-Body Irradiation 1Surveys and Questionnaires 1Mesna 1KW-2478 1Hsp90 inhibitor KU757 1Filgrastim 1Busulfan 1Bortezomib 1Acupuncture Therapy 14-(cyclopropylamino)-2-((4-(4-(ethylsulfonyl)piperazin-1-yl)phenyl)amino)pyrimidine-5-carboxamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Bronchiolitis Obliterans Syndrome × Acupuncture Therapy × Clear all
NCT01815346 2018-01-12

Acupuncture Chemotherapy-Induced Peripheral Neuropathy (CIPN) IRG

M.D. Anderson Cancer Center

Phase 1/2 Terminated
4 enrolled
Breast

Bronchiolitis Obliterans Syndrome, Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡